Analyst Consensus ?
1 unmapped firm rating excluded from the percentages.
Owens Corning · OC · FY2026 Q3 · Calendar Q4 2026
Q3 showed operating resilience in adjusted EBITDA and free cash flow, but weakness in residential construction and storm-related roofing demand, together with inflation, leaves near-term performance exposed. The Doors impairment also underscores segment-specific pressure.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Compared with Q2, management now describes weak residential construction and a second consecutive year of below-average storm activity as pressures on roofing shipments. Q3 included a $476 million Doors goodwill impairment, while the company still generated $489 million in adjusted EBITDA and $622 million in free cash flow.
Management forecasts Q4 revenue of $2.0–$2.2 billion and adjusted EBITDA margins of 10%–12%. The prior quarter had guided to slightly lower Q3 revenue and 20%–22% EBITDA margins; the new Q4 range signals a lower near-term margin outlook.
Follow OC with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 free1 unmapped firm rating excluded from the percentages.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 5, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| B of A Securities | Buy | Buy | Maintain | Oct 27, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Oct 16, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Oct 12, 2026 |
| Truist Securities | Hold | Hold | Maintain | Oct 8, 2026 |
| RBC Capital | Sector Perform | Outperform | Downgrade | Oct 7, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 6, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Oct 1, 2026 |
| Citigroup | Buy | Buy | Maintain | Aug 7, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Jun 30, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | May 8, 2026 |
| UBS | Buy | Buy | Maintain | Feb 26, 2026 |
| Jefferies | Buy | Buy | Maintain | Oct 7, 2025 |
| Loop Capital | Buy | Buy | Maintain | May 8, 2025 |
| Benchmark | Hold | Hold | Maintain | Mar 3, 2025 |
| Argus Research | Buy | Buy | Maintain | Apr 25, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | Feb 16, 2023 |
| Northcoast Research | Neutral | Buy | Downgrade | Apr 15, 2021 |
| Wolfe Research | Perform | Peer Perform | Maintain | Mar 17, 2021 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | Jul 30, 2020 |
| Nomura Instinet | Neutral | Neutral | Maintain | May 27, 2020 |
| Nomura | Neutral | Neutral | Maintain | May 27, 2020 |
| Stifel | Hold | Hold | Maintain | Apr 30, 2020 |
| Berenberg | Hold | Hold | Maintain | Jan 14, 2020 |
| Bank of America | Neutral | Buy | Downgrade | Dec 4, 2019 |
| Longbow Research | Buy | Buy | Maintain | Nov 26, 2019 |
| Buckingham Research | Buy | Neutral | Upgrade | Oct 22, 2019 |
| Buckingham | Buy | Neutral | Upgrade | Oct 22, 2019 |
| Seaport Global | Neutral | Sell | Upgrade | Jun 27, 2019 |
| Stifel Nicolaus | Hold | Buy | Downgrade | Apr 25, 2019 |
| Zelman | Hold | Buy | Downgrade | Feb 26, 2019 |
| Keybanc | Overweight | Downgrade | Aug 10, 2018 | |
| Argus | Hold | Buy | Downgrade | Jun 1, 2018 |
| MKM Partners | Neutral | Sell | Upgrade | Jul 27, 2017 |
| Wedbush | Outperform | Neutral | Upgrade | Mar 31, 2017 |
| Macquarie | Underperform | Underperform | Maintain | Dec 16, 2016 |
| Vertical Research | Buy | Hold | Upgrade | Oct 27, 2016 |
| FBR Capital | Market Perform | Market Perform | Maintain | Jul 29, 2016 |
| CL King | Buy | Neutral | Upgrade | Jun 26, 2015 |
| Northcoast | Neutral | Buy | Downgrade | Sep 30, 2014 |
| Gilford Securities | Neutral | Buy | Downgrade | Feb 15, 2013 |
| Monness, Crespi, Hardt | Neutral | Buy | Downgrade | Oct 4, 2012 |
| Monness Crespi Hardt | Neutral | Buy | Downgrade | Oct 4, 2012 |
Upside is calculated against the persisted current price $127.8. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Sam Reid | $125 | $113.69 | -2.2% | Oct 16, 2026 |
| D.A. Davidson | Garik Shmois | $143 | $114.09 | +11.9% | Oct 9, 2026 |
| Truist Financial | Analyst unavailable | $115 | $114.18 | -10.0% | Oct 8, 2026 |
| Vertical Research | Analyst unavailable | $106 | $119.78 | -17.1% | Oct 7, 2026 |
| RBC Capital | Mike Dahl | $127 | $119.78 | -0.6% | Oct 7, 2026 |
| Barclays | Analyst unavailable | $162 | $117.48 | +26.8% | Oct 6, 2026 |
| Evercore ISI | Analyst unavailable | $185 | $116.74 | +44.8% | Oct 1, 2026 |
| Wells Fargo | Analyst unavailable | $150 | $127.49 | +17.4% | Sep 11, 2026 |
| D.A. Davidson | Analyst unavailable | $190 | $146.97 | +48.7% | Aug 24, 2026 |
| Truist Financial | Analyst unavailable | $198 | $152.55 | +54.9% | Aug 6, 2026 |
| Barclays | Matthew Bouley | $177 | $152.47 | +38.5% | Aug 6, 2026 |
| Evercore ISI | Analyst unavailable | $193 | $136.62 | +51.0% | Jul 23, 2026 |
| Wells Fargo | Analyst unavailable | $165 | $141.11 | +29.1% | Jul 14, 2026 |
| Barclays | Matthew Bouley | $170 | $141.11 | +33.0% | Jul 14, 2026 |
| Goldman Sachs | Analyst unavailable | $159 | $140.26 | +24.4% | Jul 10, 2026 |
| Deutsche Bank | Analyst unavailable | $165 | $158.27 | +29.1% | Jun 30, 2026 |
| Evercore ISI | Analyst unavailable | $188 | $156.05 | +47.1% | Jun 30, 2026 |
| Barclays | Analyst unavailable | $144 | $121.67 | +12.7% | May 11, 2026 |
| Goldman Sachs | Analyst unavailable | $141 | $123.52 | +10.3% | May 7, 2026 |
| Truist Financial | Analyst unavailable | $125 | $125.86 | -2.2% | May 7, 2026 |
| Evercore ISI | Analyst unavailable | $139 | $124.24 | +8.8% | May 7, 2026 |
| Evercore ISI | Analyst unavailable | $130 | $127.01 | +1.7% | Apr 24, 2026 |
| Wells Fargo | Sam Reid | $135 | $116.58 | +5.6% | Apr 16, 2026 |
| Wells Fargo | Analyst unavailable | $155 | $137.97 | +21.3% | Feb 11, 2026 |
| Barclays | Matthew Bouley | $138 | $123.35 | +8.0% | Jan 15, 2026 |
| Wells Fargo | Analyst unavailable | $145 | $122.01 | +13.5% | Jan 14, 2026 |
| RBC Capital | Analyst unavailable | $143 | $117.07 | +11.9% | Jan 9, 2026 |
| UBS | Analyst unavailable | $160 | $113.31 | +25.2% | Jan 6, 2026 |
| Wells Fargo | Analyst unavailable | $130 | $115.99 | +1.7% | Dec 15, 2025 |
| Barclays | Analyst unavailable | $130 | $113.63 | +1.7% | Dec 8, 2025 |
| Evercore ISI | Stephen Kim | $117 | $114.12 | -8.5% | Dec 4, 2025 |
| Evercore ISI | Analyst unavailable | $121 | $106.25 | -5.3% | Nov 6, 2025 |
| Truist Financial | Analyst unavailable | $135 | $133.84 | +5.6% | Oct 9, 2025 |
| Jefferies | Philip Ng | $180 | $133.3 | +40.8% | Oct 7, 2025 |
| Evercore ISI | Stephen Kim | $153 | $136.75 | +19.7% | Oct 7, 2025 |
| Evercore ISI | Stephen Kim | $165 | $142.52 | +29.1% | May 15, 2025 |
| RBC Capital | Mike Dahl | $224 | $167.58 | +75.3% | Jan 10, 2025 |
| Loop Capital Markets | Garik Shmois | $210 | $167.58 | +64.3% | Jan 10, 2025 |
| Loop Capital Markets | Garik Shmois | $200 | $157.57 | +56.5% | Aug 7, 2024 |
| Loop Capital Markets | Garik Shmois | $215 | $175.63 | +68.2% | Jun 21, 2024 |
| Goldman Sachs | Susan Maklari | $187 | $176.58 | +46.3% | Jun 17, 2024 |
| RBC Capital | Mike Dahl | $201 | $176.86 | +57.3% | May 21, 2024 |
| Argus Research | John Eade | $182 | $163.85 | +42.4% | Apr 25, 2024 |
| RBC Capital | Mike Dahl | $192 | $165.22 | +50.2% | Apr 25, 2024 |
| Evercore ISI | Stephen Kim | $172 | $165.22 | +34.6% | Apr 24, 2024 |
| Deutsche Bank | Joe Ahlersmeyer | $100 | $89.69 | -21.8% | Jan 10, 2023 |
| Wells Fargo | Deepa Raghavan | $83 | $79.89 | -35.1% | Jul 8, 2022 |
| New Street | Rafe Jadrosich | $80 | $76 | -37.4% | Jun 17, 2022 |
| Credit Suisse | Analyst unavailable | $106 | $89.88 | -17.1% | Apr 28, 2022 |
| RBC Capital | Analyst unavailable | $95 | $88.69 | -25.7% | Apr 28, 2022 |
| Wells Fargo | Analyst unavailable | $95 | $88.76 | -25.7% | Apr 21, 2022 |
| J.P. Morgan | Analyst unavailable | $94 | $89.14 | -26.4% | Apr 20, 2022 |
| Credit Suisse | Daniel Oppenheim | $105 | $84 | -17.8% | Apr 8, 2022 |
| Wells Fargo | Deepa Raghavan | $105 | $97.31 | -17.8% | Feb 17, 2022 |
| UBS | John Lovallo | $122 | $90.96 | -4.5% | Jan 19, 2022 |
| Benchmark Co. | Reuben Garner | $135 | $95.41 | +5.6% | Jul 29, 2021 |
| Goldman Sachs | Susan Maklari | $88 | $93.25 | -31.1% | Jul 28, 2021 |
| Argus Research | John Eade | $120 | $105.52 | -6.1% | May 7, 2021 |
| Citigroup | Anthony Pettinari | $107 | $95.54 | -16.3% | Apr 30, 2021 |
Track every rating change on OC the moment it posts. Free to start.
Start freeOwens Corning provides residential and commercial building products in the United States, Europe, the Asia Pacific, and internationally. It operates through three segments: Roofing, Insulation, and Doors. The company offers laminate and strip asphalt roofing shingles, roofing components, and oxidized asphalt. It also provides high, mid, and low temperature products; thermal and acoustical batts, loosefill insulation, spray foam insulation, wet use chopped strand, foam sheathing and accessories under the Owens Corning PINK, Next Gen, and FIBERGLAS Insulation brands; and glass fiber pipe insulation, energy efficient flexible duct media, bonded and granulated stone…
| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| HL Hecla Mining Company | FY2026 Q3 · Calendar Q4 2026 | — | +13.2% | Cash generation and higher guidance offset Keno Hill constraints |
| IFF International Flavors & Fragrances Inc. | FY2026 Q3 · Calendar Q4 2026 | +2.1% | -4.9% | IFF lifts 2026 guidance, but Health & Biosciences remains a pressure point |
| HL-PB Hecla Mining Company | FY2026 Q3 · Calendar Q4 2026 | +54.0% | — | Hecla reports record Q3 cash flow and raises silver outlook |
| MLM Martin Marietta Materials, Inc. | FY2026 Q3 · Calendar Q4 2026 | — | +2.4% | Martin Marietta raises 2026 outlook as infrastructure demand holds |
| MOS The Mosaic Company | FY2026 Q3 · Calendar Q4 2026 | -1656.0% | +17.4% | Mosaic Q3: Cost Discipline Meets Sulfur and Phosphate Constraints |
| TX Ternium S.A. | FY2026 Q3 · Calendar Q4 2026 | -24.9% | -0.0% | Ternium: Mexico strength offsets Brazil and import risks |
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-05. For educational purposes only; not investment advice.